The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable

Peter J. Casterella, Dean J. Kereiakes, Steven R. Steinhubl, Russell E. Raymond, Kandice Kottke-Marchant, Karen Patel, Michelle Mueller, Monique Rosenthal, David J. Moliterno, Paul S. Teirstein

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science